Activity value 81india Buyer&Supplier,Last transaction date:
2026-06-11
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zydus lifesciences ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3004 transactions, with a transaction quantity of 2201975551.34 and a transaction weight of 4656433.5.
YearTransactionsQuantityWeight
20251546513878900135.1110282737.49
202630042201975551.344656433.5
Bill of lading data
<
1/15
>
Trade date
2026/06/11
B/L No.
hevgamd01003009
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
PHARMACEUTICAL MEDICINE FOR HUMAN USE DIVALPROEX SODIUM SPRINKLE CAPSULES 125 MG METFORMINHCL USP TABLET 500 MG TOPIRAMATE TAB 100 MG TOPIRAMATE TABLET 50 MG ZOLMITRIPTAN OD TABLETS 2 5 MG MESALAMINE DELAYED RELEASE TABLETS 1 2 GM CUSTOMS INVOICE NO XXXXXXXXXX TO 2107126833 DTD 27 04 2026 TO BE STORED AT PLUS 20 DEGREE CENTIGRADE AT ALL TIMES HMC SETTING PERCENT RH NOT MORE THAN 65 PERCENT Expand
Trade date
2026/06/11
B/L No.
nxgwamddmf68142
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
hevgamd01003007
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
PHARMACEUTICAL MEDICINE FOR HUMAN USE OXYBUTYNIN CL ER TAB 5 MG TAMSULOSIN HCL CAPSULES USP 0 4 MG CUSTOMS INVOICE NO XXXXXXXXXX TO 2107126822 DTD 25 04 2026 TO BE STORED AT PLUS 20 DEGREE CENTIGRADE AT ALL TIMES HMC SETTING PERCENT RH NOT MORE THAN 65 PERCENT Expand
Trade date
2026/06/11
B/L No.
nxgwamddmh29971
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
nxgwamddmh32631
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
nxgwamddmh37553
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
nxgwamddmf67630
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
nxgwamddmh30796
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
hevgamd01003005
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
PHARMACEUTICAL MEDICINE FOR HUMAN USEOXYBUTYNIN CL ER TAB 5 MG TAMSULOSIN HCL CAPSULES USP0 4 MG VENLAFAXINE HCL ER CAPSULES 75 MG TO BE STORED AT PLUS 20 DEGREE CENTIGRADE AT ALLTIMES HMC SETTING PERCENT RH NOT MORE THAN 6 5 PERCENT Expand
Trade date
2026/06/11
B/L No.
nxgwamddmh36444
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
nxgwamddmg78624
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
hevgamd01003008
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
PHARMACEUTICAL MEDICINE FOR HUMAN USE ACETAZOLAMIDE ER CAPSULES 500 MG MEMANTINE HCL ER CAPSULES 28 MG METFORMIN HCL USP TABLET 500 MG OXYBUTYNIN CL ER TAB 5 MG CUSTOMS INVOICE NO XXXXXXXXXX TO 2107126826 DTD 25 04 2026 TO BESTORED AT PLUS 20 DEGREE CENTIGRADE AT ALL T IMES HMC SETTING PERCENT RH NOT MORE THAN 65 PERCENT Expand
Trade date
2026/06/11
B/L No.
nxgwamddmf66985
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2026/06/11
B/L No.
hevgamd01003006
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
PHARMACEUTICAL MEDICINE FOR HUMAN USE HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG OMEPRAZOLE DR CAPSULES USP 40 MG PITAVASTATIN TABLETS 4 MG TOPIRAMATE TABLET 50 MG VENLAFAXINE HCL ER CAPSULES 75 MG CUSTOMS INVOICE NO XXXXXX6813 TO 2107126817 DTD 25 04 2026 TO BE STORED AT PLUS 20 DEGREE CENTIGRADE AT ALL TIMES H MC SETTING PERCENT RH NOT MORE THAN 65 PERCENT Expand
Trade date
2026/06/11
B/L No.
nxgwamddmh35243
Suppliers
zydus lifesciences ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
zydus lifesciences ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as human use,abs,pharm.
According to the 52wmb.com global trade database, as of 2026-06-11, the company has completed 75626 international trades,
with its main trading regions covering united states,sri lanka,burma etc.
The core products include HS30049099,HS30049079,HS30049069 etc,
often transported via mundra,port jnpt, port mundra sea etc,
and its main trading partners are eversana life science services llc,alidac healthcare myanmar li,sunshine heathcare lanka ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zydus lifesciences ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.